Jing Xu
机构:Kunming University of Science and Technology, Shanxi Agricultural University, Zhejiang A & F University, Zhejiang Sci-Tech University, Shandong University, Nantong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Nankai University, Curtin University, Kunming Medical University, Tianjin First Center Hospital, Tianjin Medical University General Hospital, Impact Assessment, Biotechnology Research Center, Hainan Provincial Academy of Agricultural Sciences, Tianjin People's Hospital, Suzhou Research Institute, Beike Biotechnology (China), Beijing Radiation Center, Taiwan Centers for Disease Control, Shandong Institute for Product Quality Inspection, Ministry of Agriculture and Rural Affairs, First Affiliated Hospital of Henan University, State Key Laboratory of Chemical Engineering, Second Affiliated Hospital of Zhejiang University, Shanghai Children's Hospital, Hebei Academy of Agriculture and Forestry Sciences, State Key Laboratory of Medicinal Chemical Biology, Tianjin Medical University, Shandong University of Science and Technology · ORCID:0000-0003-0847-4510
发表论文 305 篇 · 总被引 6628 次 · h-index 43
代表论文
- Post-translational modifications in DNA damage repair: mechanisms underlying temozolomide resistance in glioblastoma (2025 · Oncogene · 被引 12)
- Herbal Medicine‐Derived Natural Product Self‐Assembled Nanoparticles: Orchestrating Chemo‐Chemodynamic‐Immunotherapy for Tumor Combination Therapy (2025 · Advanced Healthcare Materials · 被引 9)
- Activated PLK1 promotes the migration and invasion of polyploid giant cancer cells with daughter cells via β-catenin/STAT3 signaling pathway (2025 · Human Cell · 被引 6)
- N-doped HOFs nanoenzymes enable dual-mode colorimetric/electrochemical aptasensing of AFB1 (2025 · LWT · 被引 5)
- Cannabidiol attenuates methamphetamine-induced oxidative neurotoxicity via regulating transient receptor potential vanilloid type 1 (2025 · Phytomedicine · 被引 5)
- Natural Flavonoid and Fungal Polysaccharide-Based Redox-Responsive Nanogels for Synergistic Tumor Chemo-Immunotherapy (2025 · ACS Applied Bio Materials · 被引 4)